
zzso a zzso zzso zzso is under development by zzso zzso for the potential treatment of zzso In zzso the compound zzso blocked zzso zzso and zzso zzso zzso development, which was conducted by zzso in collaboration with zzso zzso zzso demonstrated that although zzso was ineffective as a treatment for neurodegenerative conditions, a notable occurrence of unintended weight loss was observed in individuals treated with the zzso zzso data from zzso obese rats supported the hypothesis that zzso reduces body weight, and zzso has since pursued the development of the compound as an oral zzso zzso In phase II clinical trials with zzso in obese individuals, zzso reductions in body weight, body fat and waist zzso as well as improvements in other zzso zzso factors, were zzso Overall, zzso was associated with minor adverse zzso zzso caused zzso zzso in heart rate, with significant increases in blood pressure at the highest dose zzso The initial positive findings suggest that zzso may be a zzso long-term treatment for zzso with minimal cardiovascular zzso this view appears to be shared by the zzso which recently endorsed the phase III trial program for the zzso 

